AI Engines For more Details: Perplexity Kagi Labs You
Processed Starches: Consumption of highly processed starches, such as refined grains and sugary snacks, can contribute to weight gain, insulin resistance, and metabolic syndrome. These foods often lack fiber and essential nutrients and may lead to unhealthy eating patterns and chronic disease risk.
Gluten Sensitivity: Some individuals may experience adverse reactions to gluten, a protein found in wheat and other grains. For those with celiac disease or non-celiac gluten sensitivity, consuming gluten-containing starches can lead to gastrointestinal symptoms, inflammation, and other health issues.
Digestive Discomfort: In some people, consuming large quantities of starchy foods, particularly those high in resistant starch or fermentable carbohydrates, may cause digestive discomfort, bloating, gas, and diarrhea. These symptoms may be exacerbated in individuals with irritable bowel syndrome (IBS) or other gastrointestinal conditions.
High Glycemic Index: Certain starchy foods, especially refined grains and processed snacks, have a high glycemic index (GI), meaning they cause rapid spikes in blood sugar levels. Chronic consumption of high-GI foods may increase the risk of insulin resistance, type 2 diabetes, and obesity.
Antinutrients: Some starch-rich foods contain antinutrients such as phytates and lectins, which can interfere with nutrient absorption and digestion. While cooking and processing methods can help reduce the levels of these compounds, excessive consumption of certain foods high in antinutrients may pose health risks.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Propionibacterium freudenreichii | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 0.8 | 0.2 | 3 |
| ADHD | 0.8 | 0.2 | 3 |
| Allergies | 0.6 | 1.2 | -1 |
| Alzheimer's disease | 0.6 | 0.6 | |
| Anorexia Nervosa | 0.8 | 0.2 | 3 |
| Autism | 0.2 | -0.2 | |
| Bipolar Disorder | 1.2 | 1.2 | |
| Brain Trauma | 0.2 | -0.2 | |
| Chronic Fatigue Syndrome | 0.2 | 0.2 | |
| Coagulation / Micro clot triggering bacteria | 0.6 | -0.6 | |
| Colorectal Cancer | 0.6 | -0.6 | |
| COVID-19 | 0.6 | 0.6 | |
| Crohn's Disease | 0.8 | 0.8 | |
| Depression | 0.8 | 0.4 | 1 |
| Endometriosis | 0.2 | 0.2 | |
| Eosinophilic Esophagitis | 0.8 | 0.8 | |
| Epilepsy | 0.2 | -0.2 | |
| Fibromyalgia | 0.2 | -0.2 | |
| Graves' disease | 0.8 | 0.8 | |
| Halitosis | 0.2 | -0.2 | |
| Hidradenitis Suppurativa | 0.1 | -0.1 | |
| hypercholesterolemia (High Cholesterol) | 0.2 | -0.2 | |
| Inflammatory Bowel Disease | 0.2 | 0.2 | |
| Intracranial aneurysms | 0.2 | -0.2 | |
| Irritable Bowel Syndrome | 0.8 | -0.8 | |
| Long COVID | 0.8 | 0.4 | 1 |
| Lung Cancer | 0.8 | 0.8 | |
| Metabolic Syndrome | 1.2 | 0.2 | 5 |
| Mood Disorders | 2 | 1 | 1 |
| Multiple Sclerosis | 0.6 | -0.6 | |
| Neuropathy (all types) | 0.2 | -0.2 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.6 | -0.6 | |
| Obesity | 0.8 | 0.6 | 0.33 |
| obsessive-compulsive disorder | 0.6 | 0.6 | |
| Parkinson's Disease | 0.8 | 0.2 | 3 |
| Psoriasis | 0.6 | -0.6 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.2 | -0.2 | |
| Schizophrenia | 0.8 | -0.8 | |
| Systemic Lupus Erythematosus | 0.8 | 0.8 | |
| Type 2 Diabetes | 1.2 | 0.2 | 5 |
| Ulcerative colitis | 0.8 | 0.8 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.